Journal
SCIENCE
Volume 346, Issue 6205, Pages 55-+Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1255784
Keywords
-
Categories
Funding
- Karolinska Institute (DPA)
- Swedish Research Council (Vetenskapsradet)
- Swedish Cancer Society (Cancerfonden)
Ask authors/readers for more resources
The thermal stability of proteins can be used to assess ligand binding in living cells. We have generalized this concept by determining the thermal profiles of more than 7000 proteins in human cells by means of mass spectrometry. Monitoring the effects of small-molecule ligands on the profiles delineated more than 50 targets for the kinase inhibitor staurosporine. We identified the heme biosynthesis enzyme ferrochelatase as a target of kinase inhibitors and suggest that its inhibition causes the phototoxicity observed with vemurafenib and alectinib. Thermal shifts were also observed for downstream effectors of drug treatment. In live cells, dasatinib induced shifts in BCR-ABL pathway proteins, including CRK/CRKL. Thermal proteome profiling provides an unbiasedmeasure of drug-target engagement and facilitates identification of markers for drug efficacy and toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available